Abstract
Naturally occurring axonal pruning and neuronal cell death help to sculpt neuronal connections during development, but their mechanistic basis remains poorly understood. Here we report that β-amyloid precursor protein (APP) and death receptor 6 (DR6, also known as TNFRSF21) activate a widespread caspase-dependent self-destruction program. DR6 is broadly expressed by developing neurons, and is required for normal cell body death and axonal pruning both in vivo and after trophic-factor deprivation in vitro. Unlike neuronal cell body apoptosis, which requires caspase 3, we show that axonal degeneration requires caspase 6, which is activated in a punctate pattern that parallels the pattern of axonal fragmentation. DR6 is activated locally by an inactive surface ligand(s) that is released in an active form after trophic-factor deprivation, and we identify APP as a DR6 ligand. Trophic-factor deprivation triggers the shedding of surface APP in a β-secretase (BACE)-dependent manner. Loss- and gain-of-function studies support a model in which a cleaved amino-terminal fragment of APP (N-APP) binds DR6 and triggers degeneration. Genetic support is provided by a common neuromuscular junction phenotype in mutant mice. Our results indicate that APP and DR6 are components of a neuronal self-destruction pathway, and suggest that an extracellular fragment of APP, acting via DR6 and caspase 6, contributes to Alzheimer’s disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
BCLXL gene therapy moderates neuropathology in the DBA/2J mouse model of inherited glaucoma
Cell Death & Disease Open Access 10 August 2021
-
The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8
Cell Research Open Access 19 May 2021
-
The emerging role of β-secretases in cancer
Journal of Experimental & Clinical Cancer Research Open Access 29 April 2021
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout






Change history
15 March 2023
Editor’s Note: Concerns have been raised regarding some of the figures in this paper. Nature is investigating these concerns, and a further editorial response will follow as soon as possible. In the meantime, readers are advised to use caution when using results reported therein.
References
Raff, M. C., Whitmore, A. V. & Finn, J. T. Axonal self-destruction and neurodegeneration. Science 296, 868–871 (2002)
Luo, L. & O’Leary, D. D. Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 28, 127–156 (2005)
Buss, R. R., Sun, W. & Oppenheim, R. W. Adaptive roles of programmed cell death during nervous system development. Annu. Rev. Neurosci. 29, 1–35 (2006)
Saxena, S. & Caroni, P. Mechanisms of axon degeneration: from development to disease. Prog. Neurobiol. 83, 174–191 (2007)
Haase, G., Pettmann, B., Raoul, C. & Henderson, C. E. Signaling by death receptors in the nervous system. Curr. Opin. Neurobiol. 18, 284–291 (2008)
Kuida, K. et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368–372 (1996)
White, F. A., Keller-Peck, C. R., Knudson, C. M., Korsmeyer, S. J. & Snider, W. D. Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J. Neurosci. 18, 1428–1439 (1998)
Finn, J. T. et al. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J. Neurosci. 20, 1333–1341 (2000)
Kuo, C. T., Zhu, S., Younger, S., Jan, L. Y. & Jan, Y. N. Identification of E2/E3 ubiquitinating enzymes and caspase activity regulating Drosophila sensory neuron dendrite pruning. Neuron 51, 283–290 (2006)
Williams, D. W., Kondo, S., Krzyzanowska, A., Hiromi, Y. & Truman, J. W. Local caspase activity directs engulfment of dendrites during pruning. Nature Neurosci. 9, 1234–1236 (2006)
Plachta, N. et al. Identification of a lectin causing the degeneration of neuronal processes using engineered embryonic stem cells. Nature Neurosci. 10, 712–719 (2007)
Sagot, Y. et al. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci. 15, 7727–7733 (1995)
Watts, R. J., Hoopfer, E. D. & Luo, L. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron 38, 871–885 (2003)
Bodmer, J. L., Schneider, P. & Tschopp, J. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19–26 (2002)
Bossen, C. et al. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J. Biol. Chem. 281, 13964–13971 (2006)
Pan, G. et al. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett. 431, 351–356 (1998)
Zhao, H. et al. Impaired c-Jun amino terminal kinase activity and T cell differentiation in death receptor 6-deficient mice. J. Exp. Med. 194, 1441–1448 (2001)
Schmidt, C. S. et al. Enhanced B cell expansion, survival, and humoral responses by targeting death receptor 6. J. Exp. Med. 197, 51–62 (2003)
Walsh, D. M. et al. The APP family of proteins: similarities and differences. Biochem. Soc. Trans. 35, 416–420 (2007)
Reinhard, C., Hebert, S. S. & De Strooper, B. The amyloid-β precursor protein: integrating structure with biological function. EMBO J. 24, 3996–4006 (2005)
Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353–356 (2002)
Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide. Nature Rev. Mol. Cell Biol. 8, 101–112 (2007)
Wang, H. & Tessier-Lavigne, M. En passant neurotrophic action of an intermediate axonal target in the developing mammalian CNS. Nature 401, 765–769 (1999)
Campenot, R. B., Walji, A. H. & Draker, D. D. Effects of sphingosine, staurosporine, and phorbol ester on neurites of rat sympathetic neurons growing in compartmented cultures. J. Neurosci. 11, 1126–1139 (1991)
Cole, S. L. & Vassar, R. BACE1 structure and function in health and Alzheimer’s disease. Curr. Alzheimer Res. 5, 100–120 (2008)
Edwards, P. D. et al. Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency. J. Med. Chem. 50, 5912–5925 (2007)
Slunt, H. H. et al. Expression of a ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP). J. Biol. Chem. 269, 2637–2644 (1994)
Hilbich, C., Monning, U., Grund, C., Masters, C. L. & Beyreuther, K. Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. J. Biol. Chem. 268, 26571–26577 (1993)
Wang, P. et al. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-like protein 2. J. Neurosci. 25, 1219–1225 (2005)
Singh, K. K. et al. Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nature Neurosci. 11, 649–658 (2008)
Deppmann, C. D. et al. A model for neuronal competition during development. Science 320, 369–373 (2008)
LeBlanc, A., Liu, H., Goodyer, C., Bergeron, C. & Hammond, J. Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer’s disease. J. Biol. Chem. 274, 23426–23436 (1999)
Horowitz, P. M. et al. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer’s disease. J. Neurosci. 24, 7895–7902 (2004)
Guo, H. et al. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer’s disease. Am. J. Pathol. 165, 523–531 (2004)
Klaiman, G., Petzke, T. L., Hammond, J. & Leblanc, A. C. Targets of caspase-6 activity in human neurons and Alzheimer disease. Mol. Cell. Proteomics 7, 1541–1555 (2008)
Young-Pearse, T. L., Chen, A. C., Chang, R., Marquez, C. & Selkoe, D. J. Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin β1. Neural Develop. 3, 15 (2008)
Heber, S. et al. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20, 7951–7963 (2000)
Perez, R. G., Zheng, H., Van der Ploeg, L. H. & Koo, E. H. The β-amyloid precursor protein of Alzheimer’s disease enhances neuron viability and modulates neuronal polarity. J. Neurosci. 17, 9407–9414 (1997)
Han, P. et al. Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of Tau phosphorylation. J. Neurosci. 25, 11542–11552 (2005)
Matrone, C. et al. Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells. J. Alzheimers Dis. 13, 81–96 (2008)
Matrone, C., Ciotti, M. T., Mercanti, D., Marolda, R. & Calissano, P. NGF and BDNF signaling control amyloidogenic route and Aβ production in hippocampal neurons. Proc. Natl Acad. Sci. USA 105, 13139–13144 (2008)
Medana, I. M. & Esiri, M. M. Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126, 515–530 (2003)
Chiang, L. W. et al. An orchestrated gene expression component of neuronal programmed cell death revealed by cDNA array analysis. Proc. Natl Acad. Sci. USA 98, 2814–2819 (2001)
Muller, T., Meyer, H. E., Egensperger, R. & Marcus, K. The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer’s disease. Prog. Neurobiol. 85, 393–406 (2008)
Van Gool, D., De Strooper, B., Van Leuven, F. & Dom, R. Amyloid precursor protein accumulation in Lewy body dementia and Alzheimer’s disease. Dementia 6, 63–68 (1995)
Palmert, M. R. et al. Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer’s disease and recognize senile plaques. Biochem. Biophys. Res. Commun. 156, 432–437 (1988)
Bertram, L. & Tanzi, R. E. Alzheimer’s disease: one disorder, too many genes? Hum. Mol. Genet. 13, R135–R141 (2004)
Doyle, J. P. et al. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135, 749–762 (2008)
Albrecht, S. et al. Activation of caspase-6 in aging and mild cognitive impairment. Am. J. Pathol. 170, 1200–1209 (2007)
Graham, R. K. et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125, 1179–1191 (2006)
Sabatier, C. et al. The divergent Robo family protein rig-1/Robo3 is a negative regulator of slit responsiveness required for midline crossing by commissural axons. Cell 117, 157–169 (2004)
Atwal, J. K. et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 322, 967–970 (2008)
Chen, Z. et al. Alternative splicing of the Robo3 axon guidance Receptor governs the midline switch. Neuron 58, 325–332 (2008)
Higuchi, H., Yamashita, T., Yoshikawa, H. & Tohyama, M. Functional inhibition of the p75 receptor using a small interfering RNA. Biochem. Biophys. Res. Commun. 301, 804–809 (2003)
McLaughlin, T., Torborg, C. L., Feller, M. B. & O’Leary, D. D. Retinotopic map refinement requires spontaneous retinal waves during a brief critical period of development. Neuron 40, 1147–1160 (2003)
Pettmann, B. et al. Biological activities of nerve growth factor bound to nitrocellulose paper by western blotting. J. Neurosci. 8, 3624–3632 (1988)
Okada, A. et al. Boc is a receptor for sonic hedgehog in the guidance of commissural axons. Nature 444, 369–373 (2006)
Knudson, C. M. et al. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96–99 (1995)
Lee, K. F. et al. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69, 737–749 (1992)
Acknowledgements
We thank R. Axel, C. Bargmann, B. de Strooper, V. Dixit, C. Henderson, J. Lewcock, R. Scheller, R. Vassar, R. Watts, and members of the M.T.-L. laboratory for helpful discussions and suggestions, and critical reading of the manuscript, and A. Bruce for making the diagrams. We thank P. Hass and members of his laboratory (Genentech) for generation and purification of the DR6 ectodomain and APP(1–286), and W.-C. Liang and Y. Wu (Genentech) for binding experiments with purified proteins. Supported by Genentech (A.N. and M.T.-L.) and National Eye Institute grant R01 EY07025 (D.D.M.O.’L.).
Author Contributions A.N. performed most of the experiments, with the exception of the analysis of retinal projections and the experiments listed in the Acknowledgements, and co-wrote the paper. The retinotectal analysis was performed by T.M. and supervised by D.D.M.O.’L. M.T.-L. supervised or co-supervised all experiments, and co-wrote the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.N. and M.T.-L. are employees of Genentech, Inc., which has a commercial interest in some of the molecules studied here.
Supplementary information
Supplementary Information
This file contains Supplementary Figures 1-18 with Legends and a Supplementary Reference (PDF 16162 kb)
Rights and permissions
About this article
Cite this article
Nikolaev, A., McLaughlin, T., O’Leary, D. et al. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457, 981–989 (2009). https://doi.org/10.1038/nature07767
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature07767
This article is cited by
-
Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment
Cell Death & Differentiation (2022)
-
Neurogenetic disorders across the lifespan: from aberrant development to degeneration
Nature Reviews Neurology (2022)
-
The emerging role of β-secretases in cancer
Journal of Experimental & Clinical Cancer Research (2021)
-
Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer’s Disease
Acta Neuropathologica Communications (2021)
-
BCLXL gene therapy moderates neuropathology in the DBA/2J mouse model of inherited glaucoma
Cell Death & Disease (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.